Uso e rotação de opioides para dor crônica não oncológica
Use and rotation of opioids in chronic non-oncologic pain
Durval Campos Kraychete; Rioko Kimiko Sakata
Resumo
Palavras-chave
Abstract
Keywords
References
Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev. 2004.
Trescot AM, Boswell MV, Atluri SL. Opioid Guidelines in the Management of Chronic Non-Cancer Pain. Pain Phys. 2006;9:1-40.
Furlan AD, Sandoval JA, Mailis-Gagnon A. Opioids for chronic pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174(11).
Vallerand AH. The use of long-acting opioids in chronic pain management. Nurs Clin North Am. 2003;38(3):435-445.
Allan L, Richarz U, Simpson K. Transdermal fentanyl versus release oral morphine in strong-opioid naive patients with chronic low back pain. Spine. 2005;30(22):2484-2490.
Solomon DH, Avom J, Wang PS. Presciption opioid use among older adults with arthritis or low back pain. Arthritis Rheum. 2006;55(1):35-41.
Colzzi F, Mattia C. Oxycodone: Pharmacological profile and clinical data inchronic pain managment. Min Anesthesiol. 2005;71(7-8):451-460.
Langford R, McKenna F, Ratcliffe S. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: A randomized, placebo-controlled trial. Arthitis Rheum. 2006;54(6):1829-1837.
Smith MT. Opioid-induced hyperalgesia, opioid rotation and opioid combinations. Acute Pain. 2008;10:199-200.
Tellioglu T. The use of urine drug testing to monitor patients receiving chronic opioid therapy for persistent pain conditions. Med Health R I. 2008;91(9):279-280,282.
Souter KJ, Fitzgibbon D. Equianalgesic dose guidelines for long-term opioid use: Theoretical and practical considerations. Sem Anesth Perioper Med Pain. 2004;23(4):271-280.
Anderson R, Saiers JH, Abram S. Accuracy in equianalgesic dosing: Conversion dilemmas. J Pain Symptom Manage. 2001;21(5):397-406.
Brant JM. Opioid equianalgesic conversion: the right dose. Clin J Oncol Nurs. 2001;5(4):163-165.
Caims R. The use of oxicodone in cancer-related pain: a literature review. Int J Palliat Nurs. 2001;7(11):522-527.
Gammaitoni AR, Fine P, alvarez N. Clinical application of opioid equianalgesic data. Clin J Pain. 2003;19(5):286-297.
Ginsberg B, Sinatra RS, Adler LJ. Conversion to oral controlled-release oxycodone from intravenous opioid analgesic in postoperative setting. Pain Med. 2003;4(1):31-38.
Boubekeur N, Delorme J, Roussel P. Échelle d'équivalences des antalgiques (EDEA): mise au point d'un outil pour la conversion équianalgésique. Douleurs. 2006;7(4):201-206.
Benítez-Rosario MA, Salinas-Martín A, Aguirre-Jaime A. Morphine-methadone opioid rotation in cancer patients: Analysis of Dose Ratio Predicting Factors. J Pain Symptom Manage. 2009;37(6):061-068.
Coluzzi F, Pappagallo M. Opioid therapy for chronic non-cancer pain: Practice guidelines for initiation and maintenance of therapy. Min Anestesiol. 2005;71:425-433.
Grilo RM, Bertin P, Scotto di Fazano C. Opioid rotation in the treatment of joint pain: A review of 67 cases. Joint Bone Spine. 2002;69:491-494.
Moryl N, Santiago-Palma J, Kornick C. Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain. Pain. 2002;96:325-328.
Morita T, Takigawa C, Onishi H. Opioid Rotation from Morphine to fentanyl in Delirious Cancer Patients: An Open-Label Trial. J Pain Symptom Manage. 2005;30(1):96-103.
McNicol E, Horowicz-Mehler N, Fisk RA. Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review. J Pain. 2003;4:231-256.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email